Latest News
AstraZeneca posts mixed results from recent Imfinzi trials
AstraZeneca announced contrasting results from two phase three trials involving its immunotherapy drug ‘Imfinzi’, or durvalumab, on Tuesday.
Gear4music revenue falls, profit rises as expected
Online musical instrument and equipment retailer Gear4music reported final results in line with market forecasts on Tuesday, with revenue down 5% year-on-year to £144. 4m, reflecting a strategic focus on enhancing gross margins and reducing costs to prioritise profitability over revenue growth.
Saga on track despite insurance difficulties
Over-50s holidays and financial products group Saga has said it remains on track to hit targets after an in-line start to its financial year, despite ongoing challenges in the insurance market.
London pre-open: Stocks to edge up after mixed US session
London stocks were set to nudge up at the open on Tuesday following a mixed close on Wall Street.
Landsec ups Bluewater stake with £120m investment
Real estate group Landsec has raised its stake in Kent's Bluewater Shopping Centre to 66. 25% after a further £120m investment.
AstraZeneca announces positive bladder cancer trial results, Landsec raises Bluewater stake
London open The FTSE 100 is expected to open 13 points lower on Tuesday, having closed up 0. 53% on Monday at 8,281. 55.
Tuesday newspaper round-up: Energy suppliers, Boeing, Thames Water
EDF, Utilita and British Gas have been named as the worst energy suppliers for customer service, as research shows industry standards have slipped sharply. Citizens Advice said customer service ratings across the industry were among the lowest ever between January and March and average ratings had fallen by 10. 5% compared with the same period in 2021. – Guardian.
US close: Nasdaq falls on mixed day for stocks
Wall Street experienced a mixed close on Monday as traders navigated the final week of the second quarter.